Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

Cannabis Law Report

MARCH 3, 2020

In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. Washington DC: Author.

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

Veriheal

SEPTEMBER 22, 2020

The Veriheal team is incredibly proud and moved to share that our Co-Founders, Joshua Green and Samuel Adetunji, have been named on The Root 100: The Most Influential African Americans in 2020 alongside top industry and cultural trailblazers like Colin Kaepernick, LeBron James, Beyoncé Knowles-Carter, Beatrice Dixon, and Issa Rae.

Education 98

Education Banking History Media 98

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. 1 Brightfield Group 2020.

Access 105

Access Research and Development Pharmaceutical Therapy 105

NORML

JUNE 10, 2020

The deadline to submit comments to the agency is Tuesday, June 16, 2020. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. percent in 2016).” percent in 2016).”

Chronic Pain 242

Chronic Pain Therapy Patients Topical 242

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

NORML

MARCH 11, 2020

I introduced the Veterans Equal Access Act, HR 1647 because it is my responsibility as a Member of Congress to ensure that all Americans have access to medical treatment as recommended by their physicians. Today, you can make a difference and show your support for our nation’s veterans and the efficacy of medical cannabis.

Chronic Pain 333

Chronic Pain Marijuana Access Treatment 333

CannaMD

NOVEMBER 30, 2020

As Florida’s fastest growing network of medical marijuana physicians, CannaMD is committed to making sure patients have access to affordable cannabis care. The post Florida Cyber Monday Medical Marijuana Sales (2020) first appeared on CannaMD. Join 65K+ Subscribers! Get updates on more posts like this!

Safety 98

Safety Marijuana Policy Dispensary 98

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Nishtha Tripathi. School: George Washington University.

Research and Development 117

Research and Development Education Agriculture Patients 117

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

NORML

MARCH 30, 2020

They reported “circumstantial evidence” suggesting that CBD may possess antiviral acticity in a limited number of conditions, specifically in the treatment of hepatitis C and Karposi sarcoma. Misleading claims represent both a threat to public health and a violation of consumer access to accurate information.”

CBD 299

CBD Clinical Trials Data Treatment 299

Cannabis Law Report

NOVEMBER 9, 2020

09 Nov 2020 Medicinal Cannabis And Treatment Access. They write. The information below has been prepared in conjunction with our partner, Little Green Pharma. Claiming … Read More. The post Australian Insurer HIF Provides Coverage For Medical Cannabis first appeared on Cannabis Law Report.

Treatment 98

Treatment Access Medicine Cannabis 98

CannaMD

APRIL 19, 2020

As the coronavirus crisis continues, CannaMD remains committed to helping patients access treatment as safely as possible. Offer valid April 16-30, 2020. This offer is available April 17-20, 2020. To learn more about 4/20, check out one of our most popular posts: Where Did “420” Come From? Get Started.

Seed-To-Sale 65

Seed-To-Sale Marijuana Wellness and Beauty Patients 65

CannaMD

SEPTEMBER 5, 2020

We strongly believe that all patients should have affordable access to the medication they need – which is why we’re excited to share the holiday discounts and sales below! The post Florida Medical Marijuana: Labor Day Sales [2020] first appeared on CannaMD. CannaMD would like to wish everyone a safe and fun-filled Labor Day weekend!

Seed-To-Sale 63

Seed-To-Sale Safety Marijuana Policy 63

Cannabis Law Report

SEPTEMBER 10, 2021

PsiloThera’s clinical focus is the development of treatments for Mental Illnesses, Cognitive Diseases & Neurological Disorders. Department of Veterans Affairs (VA) announced in June 2020 that Tele-Health “VA Video Connect” appointments increased by 1,000% between February and May of 2020.

Microdosing 98

Microdosing Research and Development Therapy Treatment 98

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. 30, the end of the 2020 fiscal year, the industry tallied more than $330 million in sales, according to the state Treasury. Between Dec.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

CannaMD

JULY 2, 2020

We strongly believe that all patients should have affordable access to the medication they need – which is why we’re excited to share the holiday discounts and sales below! NOTE: CannaMD is not directly affiliated with any dispensary. Please contact dispensaries directly with any product and/or sales questions. Find Out if You Qualify.

Safety 81

Safety Policy Marijuana Dispensary 81

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Cannigma

AUGUST 26, 2021

percent), according to the United Nations World Drug Report for 2020.In In addition, a survey published in July 2020 found that 41% of Australians support cannabis legalization, and 37% are opposed. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

NOVEMBER 17, 2021

There is one problem, Malaysia currently has no registered cannabis-based treatment. billion by 2024, according to a report published in 2020 by Prohibition Partners. The products would need to be registered with the Drug Control Authority (DCA) as prescribed by the Control of Drugs and Cosmetics Regulation. Sativex in Malaysia.

Research and Development 111

Research and Development Patients Treatment Pharmaceutical 111

NORML

JANUARY 19, 2020

House Bill 1359 would create a 5 year medical marijuana pilot program, allowing patients to access their medicine from licensed dispensaries. Send a message to your lawmakers in support of medical marijuana access. Legislation is pending, Senate Bill 697, to expand access to medical marijuana. IN resident? NH resident?

Legislation 244

Legislation Decriminalization Access Patients 244

TheAnswerPage

MAY 18, 2022

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. off label)? Subsidiary Greenwich Biosciences, Inc. See the Answer.

Pharmaceutical 52

Pharmaceutical Treatment Access CBD 52

NORML

MAY 26, 2020

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 253

Clinical Trials Chronic Pain Cannabinoids Patients 253

TheAnswerPage

JUNE 12, 2021

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. link] accessed Mar 31, 2021. off label)? GW Pharmaceuticals website.

Pharmaceutical 52

Pharmaceutical Access Treatment CBD 52

Cannabis Law Report

AUGUST 12, 2021

loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. million during the same period in 2020. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

DECEMBER 22, 2019

“Living with or caring for someone with severe epilepsy is exceptionally challenging, especially as there are so few treatments available for the rare forms of the condition. Thousands of people including children will now have access to this treatment, which has the potential to make a real difference.”. Source: [link].

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

SpeedWeed

AUGUST 9, 2021

Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The hospital’s young patients will now receive treatment from pharmaceutical-grade cannabis oil, purified and highly concentrated. Last November, the Argentine Government issued Decree 883/2020.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

TheAnswerPage

AUGUST 17, 2021

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. off label)? Subsidiary Greenwich Biosciences, Inc.

Pharmaceutical 52

Pharmaceutical Treatment Access CBD 52

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Veriheal

MAY 31, 2022

1, 2020, and July 31, 2021—a 43% increase from the same period a year before. opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MMJ Recs

FEBRUARY 19, 2022

In 2017, a law was enacted in Virginia that allowed people with specific types of intractable epilepsy to access cannabis oil, as long as they had a doctor certify they needed it and it could help with their condition. On July 1, 2020, Virginia lawmakers passed perhaps the most significant improvements.

Marijuana 52

Marijuana Epilepsy Access Conditions 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

The Cannigma

DECEMBER 20, 2022

Since 2011, treatment may be offered to drug-dependent offenders as an alternative to prison only if the offender is sentenced to imprisonment for six months to two years and agrees to undergo the treatment course. There is no national cannabis program; patients can only access cannabinoid-based medications, not the plant itself.

Law 52

Law Decriminalization Cannabinoids Treatment 52

Cannabis Law Report

MARCH 24, 2020

Mar 20, 2020. Governors and legislative leaders urged to preserve and ensure cannabis access amid social distancing. The Marijuana Policy Project is tracking state measures to preserve access in light of COVID-19 here. Hundreds of thousands of Americans have adopted cannabis into their treatment regimens.

Law 53

Law Epilepsy Treatment Access 53